Fu-Liang Wang
Overview
Explore the profile of Fu-Liang Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
27
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu Y, Liu W, Zhu G, Wang F, Chen Q
Mol Med Rep
. 2018 Mar;
17(5):7113-7121.
PMID: 29568871
Multidrug resistance protein 4 (MRP4) is capable of transporting acyclic nucleotide phosphonates, but little is known about its role in lamivudine (LAM) and entecavir (ETV) transport. In the present study,...
2.
Li X, Liang H, Cao Z, Xiao Q, Xiao Z, Song L, et al.
Mater Sci Eng C Mater Biol Appl
. 2016 Dec;
72:26-33.
PMID: 28024585
A simple and rapid mercury ion selective electrode based on 1-undecanethiol (1-UDT) assembled Au substrate (Au/1-UDT) has been well constructed. 1-UDT was for the purpose of generating self-assembled monolayer on...
3.
Wang F, Sun X, Wang F, Jiang L, Xu E, Guo J
Int J Infect Dis
. 2014 Jul;
26:67-70.
PMID: 25008769
Objectives: The aims of this study were to determine the mechanism of an outbreak of measles in adults and to provide scientific measures for putting forward a measles elimination program....
4.
Liu J, Xie Y, Wang F, Zhang L, Zhang Y, Luo H
Biomed Pharmacother
. 2012 Dec;
67(1):78-87.
PMID: 23201008
The DNA methylation inhibitor 5-Aza-2'-deoxycytidine (5-Aza-CdR) has increasingly attracted worldwide attention for its antineoplastic potential. The cytotoxitic mechanisms, however, especially, the relative contribution of silenced genes reactivation by demethylation and...
5.
Liu J, Zhang Y, Xie Y, Wang F, Zhang L, Deng T, et al.
Oncol Rep
. 2012 Jun;
28(2):545-52.
PMID: 22664909
The DNA methylation inhibitor 5-aza-2'-deoxycytidine (5-Aza-CdR) has therapeutic value for the treatment of cancer. However, the mechanism by which 5-Aza-CdR induces antineoplastic activity is not clear. The efficacy of 5-Aza-CdR...